Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group. - Blay,J.Y.; Le Cesne,A.; Ray-Coquard,I. (J Clin Oncol, 2007)